which showed that the mean systolic strain rate (SR) of left atrial (LA) segments (SR-LAs) in a dilated LA group and non-dilated LA group was significantly lower than that in normotensive (NT) subjects, irrespective of the presence or absence of left ventricular hypertrophy (LVH); that the mean SR-LAs in hypertensive (HT) patients was lower than that in NT subjects; that the mean SR-LAs in a non-dilated LA group administered renin angiotensin system (RAS) inhibitors was equivalent to that in NT subjects; and that in HT patients, the mean SR-LAs, as an index of LA reservoir function, decreased before development of LA enlargement and LVH. These results suggested that treatment with RAS inhibitors preserves LA reservoir function in HT patients without dilated LA, and that SR imaging can detect LA dysfunction in HT patients and is useful for evaluation of the therapeutic benefit on LA reservoir function. The methods and interpretation of the results, however, raise several concerns.
Letter to the Editor

Noninvasive Assessment of Left Atrial Function by Strain Rate Imaging in Patients with Hypertension: A Possible Beneficial Effect of Renin-Angiotensin System Inhibition on Left Atrial Function
To the Editor: I read with great interest the study by Dr. Kokubu et al. (1) , which showed that the mean systolic strain rate (SR) of left atrial (LA) segments (SR-LAs) in a dilated LA group and non-dilated LA group was significantly lower than that in normotensive (NT) subjects, irrespective of the presence or absence of left ventricular hypertrophy (LVH); that the mean SR-LAs in hypertensive (HT) patients was lower than that in NT subjects; that the mean SR-LAs in a non-dilated LA group administered renin angiotensin system (RAS) inhibitors was equivalent to that in NT subjects; and that in HT patients, the mean SR-LAs, as an index of LA reservoir function, decreased before development of LA enlargement and LVH. These results suggested that treatment with RAS inhibitors preserves LA reservoir function in HT patients without dilated LA, and that SR imaging can detect LA dysfunction in HT patients and is useful for evaluation of the therapeutic benefit on LA reservoir function. The methods and interpretation of the results, however, raise several concerns. Kokubu et al. (1) report that 80 patients with HT were studied, in whom relevant history included hypercholesterolaemia, diabetes, and paroxysmal atrial fibrillation, which could affect LA systolic or diastolic function. Despite this fact, the relations of these diseases to LA systolic or diastolic function were not well described. This raises the question: was there any relation between these aspects of the patient histories and the results of this study?
In addition, the HT patients had greater body mass index (BMI) than did the NT patients, which could have affected LA systolic or diastolic function. However, Kokubu et al. (1) did not adequately describe the relation of BMI to LA systolic or diastolic function. Here again, did the relation between BMI and these functions affect the results? found between hypertensive patients with and those without hypercholesterolemia. In normotensive subjects, neither the mean SR-LAs nor the mean SR-LAa was significantly different between the subjects with and those without hypercholesterolemia.
As shown in our Results section, the body mass index (BMI) showed no correlation with either mean SR-LAs (p= 0.08) or mean SR-LAa (p= 0.88). The prevalence of obesity, which was defined as BMI > 25 kg/m 2 , was comparable between the HT group and normotensive group (32% vs. 48%, respectively). Neither the mean SR-LAs nor the mean SR-LAa was not significantly different between the hypertensive patients with and without obesity.
In short, we believe that the presence of DM, hypercholesterolemia, obesity and/or a history of paroxysmal AF could have negligibly influenced the results of our study. We agree that other large-scale prospective studies will be needed to examine whether the presence of these factors adversely effects LA function as assessed by strain rate imaging. 
Nobuaki
